Skip to main content
. 2021 Mar 2;4(3):e210490. doi: 10.1001/jamanetworkopen.2021.0490

Table 2. Factors Associated With Premature Discontinuation of I/Q.

Factor Premature discontinuation, No./total No. (%)a OR (95% CI) P value AOR (95% CI)b P value
Age, y
ā‰„60 17/136 (12.5) 1 [Reference] NA 1 [Reference] NA
50-59 39/200 (19.5) 1.7 (0.9-3.1) .09 1.9 (0.9-3.6) .07
40-49 42/234 (18.0) 1.5 (0.8-2.8) .17 1.8 (0.9-3.5) .09
<40 81/385 (21.0) 1.9 (1.1-3.3) .03 2.5 (1.3-4.8) .01
Gender
Male 121/721 (16.8) 1 [Reference] NA 1 [Reference] NA
Female 56/220 (25.5) 1.7 (1.1-2.4) .004 1.8 (1.2-2.7) .01
Transgender or other 2/14 (14.3) 0.8 (0.2-3.7) .81 0.4 (0.1-2.0) .26
Race/ethnicity
White 43/217 (19.8) 1 [Reference] NA 1 [Reference] NA
Black 52/178 (29.2) 1.7 (1.0-2.7) .03 1.7 (1.0-2.9) .045
Latinx 63/432 (14.6) 0.7 (0.5-1.1) .09 0.9 (0.5-1.5) .94
Asian or Pacific Islander 8/76 (10.5) 0.5 (0.2-1.1) .07 0.7 (0.3-1.6) .36
Multiethnic, other, or unknown 13/52 (25.0) 1.3 (0.7-2.7) .41 1.4 (0.6-3.2) .39
Living situation
Home, apartment, RV, or trailer 30/270 (11.1) 1 [Reference] NA 1 [Reference] NA
Homeless
Sheltered 43/276 (15.6) 1.5 (0.9-2.4) .13 1.7 (0.9-3.3) .13
Unsheltered 76/192 (39.6) 5.2 (3.3-8.4) <.001 4.5 (2.3-8.6) <.001
Congregate living setting or SRO 17/140 (12.1) 1.1 (0.6-2.1) .76 1.3 (0.7-2.7) .42
Other or unknown 13/77 (16.9) 1.6 (0.8-3.3) .18 1.2 (0.5-2.9) .68
Referral source
Outpatient 21/96 (21.9) 1 [Reference] NA 1 [Reference] NA
Hospital 84/341 (24.6) 1.2 (0.7-2.1) .58 1.1 (0.6-2.0) .75
Homeless service provider or shelter 23/158 (14.6) 0.6 (0.3-1.1) .14 0.5 (0.3-1.1) .10
Surveillance or field testing 12/106 (11.3) 0.5 (0.2-1.0) .05 0.7 (0.3-1.7) .48
Other 24/146 (16.4) 0.7 (0.4-1.3) .29 0.6 (0.3-1.2) .13
Missing 15/108 (13.9) 0.6 (0.3-1.2) .14 0.5 (0.2-1.1) .09
COVID-19 status
COVID-19 diagnosis 47/438 (10.7) 1 [Reference] NA 1 [Reference] NA
PUI 89/358 (24.9) 2.8 (1.9-4.0) <.001 1.5 (0.9-2.5) .09
Close contact 37/141 (26.2) 3.0 (1.8-4.8) <.001 2.6 (1.5-4.6) .001
None of the above 2/5 (40.0) 5.5 (0.9-34.0) .06 4.0 (0.6-29.0) .17
Missing 4/13 (30.8) 3.7 (1.1-12.5) .04 4.8 (1.1-21.7) .04
Elixhauser medical conditionc,d
No 97/583 (16.6) 1 [Reference] NA 1 [Reference] NA
Yes 63/274 (23.0) 1.5 (1.0-2.1) .03 1.4 (0.9-2.2) .17
Elixhauser mental health disorderd,e
No 110/654 (16.8) 1 [Reference] NA 1 [Reference] NA
Yes 50/203 (24.6) 1.6 (1.1-2.4) .01 1.0 (0.6-1.6) .89
Elixhauser substance use disorderd,f
No 104/639 (16.3) 1 [Reference] NA 1 [Reference] NA
Yes 56/218 (25.7) 1.8 (1.2-2.6) .002 0.8 (0.05-1.4) .42
Jail stay in past yeard
No 131/772 (17.0) 1 [Reference] NA 1 [Reference] NA
Yes 29/85 (34.1) 2.5 (1.6-4.1) <.001 1.6 (0.7-2.3) .39

Abbreviations: AOR, adjusted odds ratio; COVID-19, coronavirus disease 2019; I/Q, isolation and quarantine; NA, not applicable; OR, odds ratio; PUI, persons under investigation; RV, recreational vehicle; SRO, single-room occupancy hotel.

a

Nā€‰=ā€‰955 (excludes patients elevated to a higher level of care and discharges for administrative and safety reasons).

b

Model adjusted for calendar week of referral.

c

Elixhauser medical condition was defined as having 2 or more diagnosis codes in the current and past 2 fiscal years in medical records and included rheumatic arthritis, neurologic disorders, paralysis, cancer, kidney failure, liver disease, peptic ulcer disease, hypothyroidism, weight loss, obesity, diabetes, fluid and electrolyte disorders, chronic pulmonary disease, pulmonary circulation disorder, peripheral vascular disease, hypertension, congestive heart failure, valvular disease, cardiac arrhythmias, coagulopathy, blood loss anemia, deficiency anemia, and AIDS or HIV.

d

Data not shown for records unmatched to administrative data.

e

Elixhauser mental health disorder was defined as having 2 or more diagnosis codes in the current and past 2 fiscal years in medical records and included psychoses and depression.

f

Elixhauser substance use disorder was defined as having 2 or more diagnosis codes in the current and past 2 fiscal years in medical records and included alcohol or drug use.